Abstract
Background Cutaneous psoriasis precedes joint disease in 84% of patients with psoriatic arthritis. We believe that skin involvement should be considered when deciding how to treat psoriatic arthritis. Objective The goal of our study was to investigate how the severity of skin disease influenced the management of psoriatic arthritis. Methods Fifty patients with psoriatic arthritis and cutaneous involvement were studied. The severity of joint and skin involvement was evaluated. Treatment decisions for each patient were based on the most severe presentation between skin and joint involvement. Results Treatment decisions were guided and were compared by the most severe skin involvement in 22/50 patients (44%), by the most severe joint involvement in 16 patients (32%), and by both skin and joint involvement in 12 patients (24%). There were no statistically significant differences (p <0.472). Conclusion Treatment decisions in patients with psoriatic arthritis should be made in conjunction with decisions about skin treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
